However, she has acknowledged using weight-loss injections and discussed the challenges of maintaining weight loss, aligning with public discussions around GLP-1 agonists like Ozempic and Wegovy
Excess body fat, especially around the waist, directly promotes fat buildup and inflammation in the liver
WuGBersingerNAMuellerMDvonWolff M
We assessed over 50 pharmacies on their peptide-specific expertise, breadth of formulary, sterile compounding infrastructure, third-party testing rigor, regulatory compliance, provider support, and patient outcomes
Plaintiffs argue that Novo Nordisk and Eli Lilly failed to adequately warn patients about these risks
Mitra MS, Lancaster K, Adedeji AO, Palanisamy GS, Dave RA, Zhong F, Holdren MS, Turley SJ, Liang WC, Wu Y, Meng YG, Vernes JM, Schutten MM